(2026). Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma. PeerJ.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Targetome Profile of Hsa-miR-93-5p Is Resistant to Isoform Formation in Prostate Adenocarcinoma."
PeerJ 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Targetome Profile of Hsa-miR-93-5p Is Resistant to Isoform Formation in Prostate Adenocarcinoma."
PeerJ, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.